Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2011
Biochemistry, Genetics and Molecular Biology journal rankings 2011
1,064 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 1,064 ranked journals in 2011. Its median journal scores above the world average: OJR 1.03 against 1.00, up 0.04 on 2010. A journal needs OJR 1.59 to reach Q1. The top three are Nature Genetics, Pharmacological Reviews, and Cell.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences1,064 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1Nature GeneticsNature Portfolio · United States | 12.38Q1 | 32.39 0.99 up from 2010 | 848 | 58% | $12,690 | ||
2Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 9.65Q1 | 24.68 2.33 up from 2010 | 59 | 42% | $4,500 | ||
3CellCell Press · United States | 9.20Q1 | 24.56 1.27 up from 2010 | 1,701 | 99% | $11,400 | ||
4NatureNature Portfolio · United Kingdom | 6.82Q1 | 11.74 0.34 up from 2010 | 10,066 | 30% | $12,690 | ||
5Biotechnology AdvancesElsevier BV · United Kingdom | 6.53Q1 | 10.77 1.18 up from 2010 | 255 | 18% | $5,460 | ||
6Cell stem cellElsevier BV · United States | 6.49Q1 | 17.95 0.89 up from 2010 | 573 | 100% | $10,400 | ||
7FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 6.29Q1 | 12.83 0.23 down from 2010 | 175 | 67% | $3,297 | ||
8Molecular Aspects of MedicineElsevier BV · United Kingdom | 5.66Q1 | 11.67 2.89 down from 2010 | 84 | 33% | $5,220 | ||
9Nature CommunicationsOANature Portfolio · United Kingdom | 5.59Q1 | 9.88no 2010 value | 153 | 98% | $6,990 | — | |
10Nature Cell BiologyNature Portfolio · United Kingdom | 5.57Q1 | 15.28 1.19 up from 2010 | 699 | 53% | $12,690 | ||
11Systematic BiologyOxford University Press · United States | 5.49Q1 | 8.62 0.49 down from 2010 | 245 | 40% | $2,166 | ||
12ScienceAmerican Association for the Advancement of Science · United States | 5.47Q1 | 8.26 0.86 up from 2010 | 13,238 | 19% | — | ||
13Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 5.41Q1 | 12.62 0.56 down from 2010 | 1,410 | 99% | $5,200 | ||
14Nature BiotechnologyNature Portfolio · United States | 5.20Q1 | 9.36 0.95 down from 2010 | 1,103 | 26% | $12,690 | ||
15Nature ProtocolsNature Portfolio · United States | 5.16Q1 | 10.49 0.33 down from 2010 | 542 | 43% | — | ||
16Progress in Lipid ResearchElsevier BV · United Kingdom | 5.11Q1 | 11.94 1.25 up from 2010 | 89 | 24% | $5,530 | ||
17Cell MetabolismCell Press · United States | 4.98Q1 | 11.41 3.34 down from 2010 | 438 | 99% | $10,400 | ||
18Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.85Q1 | 11.28 0.25 up from 2010 | 12,204 | 99% | — | ||
19Molecular CellElsevier BV · United States | 4.79Q1 | 13.56 0.17 up from 2010 | 1,121 | 100% | $10,400 | ||
20The American Journal of Human GeneticsElsevier BV · United States | 4.75Q1 | 11.30 0.01 up from 2010 | 747 | 90% | $5,150 | ||
21Orphanet Journal of Rare DiseasesOABioMed Central · United Kingdom | 4.75Q1 | 8.61 0.58 up from 2010 | 106 | 100% | $2,990 | ||
22Drug Resistance UpdatesElsevier BV · United Kingdom | 4.66Q1 | 10.40 0.72 down from 2010 | 61 | 24% | $5,410 | ||
23Cell Host & MicrobeCell Press · United States | 4.56Q1 | 11.19 0.42 up from 2010 | 411 | 100% | $10,400 | ||
24PLoS BiologyOAPublic Library of Science · United States | 4.35Q1 | 9.97 0.39 down from 2010 | 903 | 100% | $5,500 | ||
25Briefings in BioinformaticsOAOxford University Press · United Kingdom | 4.30Q1 | 7.61 4.51 down from 2010 | 163 | 77% | $3,885 | ||
26Developmental CellElsevier BV · United States | 4.28Q1 | 11.86 0.71 up from 2010 | 646 | 100% | $10,400 | ||
27Molecular CytogeneticsOABioMed Central · United Kingdom | 4.13Q1 | 11.10 7.84 up from 2010 | 77 | 100% | $3,290 | ||
28Critical Reviews in MicrobiologyTaylor & Francis · United States | 4.12Q1 | 7.74 0.38 up from 2010 | 57 | 4% | — | ||
29Nature MethodsNature Portfolio · United States | 4.11Q1 | 9.39 0.39 down from 2010 | 956 | 35% | $12,690 | ||
30TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 4.11Q1 | 5.74 0.13 down from 2010 | 404 | 12% | $5,150 | ||
31Nature Structural & Molecular BiologyNature Portfolio · United States | 4.05Q1 | 11.81 0.60 up from 2010 | 743 | 63% | $12,690 | ||
32Pharmacology & TherapeuticsElsevier BV · United States | 4.00Q1 | 9.33 0.05 up from 2010 | 315 | 38% | $5,660 | ||
33Molecular Systems BiologyOASpringer Nature · United Kingdom | 3.99Q1 | 9.85 0.81 down from 2010 | 290 | 100% | $7,990 | ||
34Journal of Medical GeneticsBMJ · United Kingdom | 3.98Q1 | 10.02 3.18 up from 2010 | 434 | 41% | — | ||
35PLoS GeneticsOAPublic Library of Science · United States | 3.96Q1 | 10.53 0.34 down from 2010 | 1,321 | 100% | $3,043 | ||
36Nature Chemical BiologyNature Portfolio · United States | 3.86Q1 | 10.16 1.02 up from 2010 | 589 | 42% | $12,690 | ||
37Expert Reviews in Molecular MedicineOACambridge University Press · United Kingdom | 3.85Q1 | 9.81 1.26 up from 2010 | 115 | 50% | $3,550 | ||
38Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 3.84Q1 | 10.24 0.05 down from 2010 | 133 | 34% | $5,070 | ||
39The EMBO JournalOASpringer Nature · Germany | 3.62Q1 | 9.60 0.95 down from 2010 | 1,051 | 95% | $7,990 | ||
40Circulation ResearchLippincott Williams & Wilkins · United States | 3.48Q1 | 9.25 0.36 up from 2010 | 1,086 | 41% | — | ||
41Human Molecular GeneticsOxford University Press · United Kingdom | 3.46Q1 | 8.61 0.30 up from 2010 | 1,464 | 77% | $4,390 | ||
42Cancer ResearchAmerican Association for Cancer Research · United States | 3.44Q1 | 9.14 0.02 down from 2010 | 3,675 | 8% | — | ||
43Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 3.39Q1 | 7.25 2.97 down from 2010 | 114 | 28% | $4,160 | ||
44mBioOAAmerican Society for Microbiology · United States | 3.38Q1 | 6.57no 2010 value | 70 | 100% | $3,900 | — | |
45EMBO Molecular MedicineOASpringer Nature · United Kingdom | 3.38Q1 | 7.79 1.35 up from 2010 | 116 | 100% | $7,990 | ||
46Critical Reviews in BiotechnologyTaylor & Francis · United States | 3.30Q1 | 5.83 0.62 down from 2010 | 74 | 4% | — | ||
47Genome biologyOABioMed Central · United Kingdom | 3.28Q1 | 9.45 2.08 up from 2010 | 731 | 100% | $5,490 | ||
48PhysiologyAmerican Physiological Society · United States | 3.25Q1 | 7.04 0.13 down from 2010 | 139 | 22% | — | ||
49Stem CellsOxford University Press · United States | 3.24Q1 | 8.39 0.01 up from 2010 | 917 | 56% | $4,477 | ||
50Nanomedicine Nanotechnology Biology and MedicineElsevier BV · United States | 3.21Q1 | 6.82 1.15 up from 2010 | 240 | 20% | $3,670 |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology901
- Genetics99
- Cell Biology21
- Cancer Research20
- Molecular Medicine7
- Biophysics6
- Biochemistry3
- Clinical Biochemistry2
- Structural Biology2
- Developmental Biology1
- Endocrinology1
- Physiology1
- Aging0
- Biotechnology0
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
309 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 1,064
- Window papers (baseline)
- 595,190 +19.6% from indicator year 2008
- Median OJR
- 1.03 +11.4% from indicator year 2008
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.